DocGo (NASDAQ:DCGO), which combined with Motion in November 2021, announced that it will redeem all of its outstanding warrants at 5 pm ET September 16 at a redemption price of $0.10 per warrant.
Holders may also swap their warrants on a cashless basis for 0.2233 of a common share as a part of the exchange. The company is allowed to launch this call because the last share price of its shares was $10 or above on August 12.
In fact, the company has been on a tear, rising +31.3% over the past month. It closed yesterday at $10.20 on the backs of three successive profitable quarters as a public company. DocGo most recently beat its second quarter revenue estimates by about 10% and upped its revenue guidance for the year.
Holders may also exercise their warrants at $11.50 per share until September 16.
DocGo provides “last-mile” medical services such as medical transportation and telehealth, and it has been active in providing mobile COVID-19 stations throughout the country. This morning, it also announced that it has been contracted to provide mobile health services to Medicare-eligible patients covered by New Jersey’s largest health insurer, Horizon.
Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...